Palvella Therapeutics (PVLA) Accumulated Depreciation & Amortization (2016 - 2023)
Historic Accumulated Depreciation & Amortization for Palvella Therapeutics (PVLA) over the last 11 years, with Q2 2023 value amounting to $10.5 million.
- Palvella Therapeutics' Accumulated Depreciation & Amortization rose 2760.46% to $10.5 million in Q2 2023 from the same period last year, while for Jun 2023 it was $10.5 million, marking a year-over-year increase of 2760.46%. This contributed to the annual value of $9.6 million for FY2022, which is 2500.97% up from last year.
- Palvella Therapeutics' Accumulated Depreciation & Amortization amounted to $10.5 million in Q2 2023, which was up 2760.46% from $10.0 million recorded in Q1 2023.
- Palvella Therapeutics' Accumulated Depreciation & Amortization's 5-year high stood at $10.5 million during Q2 2023, with a 5-year trough of $3.3 million in Q1 2019.
- Over the past 5 years, Palvella Therapeutics' median Accumulated Depreciation & Amortization value was $6.5 million (recorded in 2021), while the average stood at $6.4 million.
- Per our database at Business Quant, Palvella Therapeutics' Accumulated Depreciation & Amortization skyrocketed by 218.27% in 2019 and then skyrocketed by 6815.58% in 2021.
- Palvella Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $3.6 million in 2019, then surged by 63.02% to $5.8 million in 2020, then skyrocketed by 32.71% to $7.7 million in 2021, then grew by 25.01% to $9.6 million in 2022, then rose by 9.06% to $10.5 million in 2023.
- Its Accumulated Depreciation & Amortization stands at $10.5 million for Q2 2023, versus $10.0 million for Q1 2023 and $9.6 million for Q4 2022.